Abstract CT055: PAVO: A phase-II, open label, single arm study of niraparib in patients with locally advanced/metastatic PALB2 mutated tumors by Zhang, Tian, Weart, Thomas, Weiss, Matthias, Murray, Drew, Jhawer, Minaxi, Huynh, Edward, Kato, Shumei, Cummings, Amy, Usha, Lydia, Bhinder, Arvinder, Desai, Rajiv, Johnson, Brad, Avadhani, Anjali, Vibat, Cecile Rose T., Lopez, Lauren, Driscoll, Brynna, Ward, Annajane, Rice, Christie K., Donovan, Blathnaid, Sherrin, Scott, Robble, Mykel, O'Leary, Stephanie, Blackwell, Kimberly, Aziez, Amine, Petrone, Stephanie, Harnden, Kathleen, Strickland, Kimberly, Reid, Sonya, Robson, Mark, Paulson, Andrew S., Dowlati, Afshin

Get full text